Screener
Lexicon Pharmaceuticals LXRX Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Assets | As of June 30, 2026 / (unaudited) | As of December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $40,924 | $34,326 |
| Short-term investments | 149,686 | 61,904 |
| Accounts receivable, net | 1,643 | 2,384 |
| Inventory | 1,196 | 281 |
| Prepaid expenses and other current assets | 3,128 | 3,000 |
| Total current assets | 196,577 | 101,895 |
| Property and equipment, net | 1,651 | 1,863 |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's accounts receivable?
- Lexicon Pharmaceuticals (LXRX) reported accounts receivable of $1.64M in Q2 2026.
- How has Lexicon Pharmaceuticals's accounts receivable changed year-over-year?
- Lexicon Pharmaceuticals's accounts receivable decreased by 24.7% year-over-year, from $2.18M to $1.64M.
- What is the long-term trend for Lexicon Pharmaceuticals's accounts receivable?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's accounts receivable has grown at a 43.3% compound annual growth rate (CAGR), from $395K to $2.38M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Lexicon Pharmaceuticals's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude